News

San Diego’s Halozyme Therapeutics will get $30 million upfront, with the possibility of hundreds of millions more, under a licensing agreement with a European biotechnology company announced Monday. Argenx, based in the Netherlands, is licensing Ha… […]

SAN DIEGO–(BUSINESS WIRE)–Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces closing an investment in Dianomi Therapeutics, Inc., a biopharmaceutical company focused on improving the delivery and efficacy of large and small molecules in the… […]

Magnolia Medical Technologies, a Seattle-based manufacturer of devices for collecting blood and bodily fluids, announced this week it has raised $20 million in equity funding to ramp up sales of its flagship product. The funding comes as Magnolia and S… […]

A cancer-fighting gene known as the “guardian of the genome” actually promotes certain tumors, according to a study by UC San Diego researchers. That means drugs that affect its activity may backfire in some cases, fueling the tumor’s growth. Calle… […]

Gossamer Bio is dropping its plan to pursue a little-used path to the public markets and will instead return to a conventional IPO that is reviewed by securities regulators. The company initially filed for an IPO as activity at the SEC ground to a halt… […]

Taylor Cavanah, whose background is in physics, once caused a fellow scientist to do a spit take after learning Cavanah runs a software startup focused on pet care. Just as surprising is the tale of how Cavanah and co-founders Ken Tsui and Aaron Bannis… […]

LYMINGTON, United Kingdom–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/2019ICPCPlenary?src=hash" target="_blank"gt;#2019ICPCPlenarylt;/agt;–The International Cable Protection Committee welcomes your participation at its… […]